Browse

Why longevity entrepreneur Bryan Johnson’s chronic disease is notoriously difficult to diagnose.

The U.K. drugmakers added to a series of recent tie-ups with Chinese counterparts amid broader scrutiny of such transactions in the U.S.

For the second year in a row, many Affordable Care Act insurers are proposing double-digit premium increases, driven by rising medical costs as well as federal policy changes.